EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

Ersilia Nigro, Daniela D'Arco, Fiorenzo Moscatelli iD, Antonio Pisani, Maria Amicone iD, Eleonora Riccio, Ivana Capuano, Francesca Argentino, Marcellino Monda iD, Giovanni Messina, Aurora Daniele, Rita Polito

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25116243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ersilia Nigro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Ambientali, Biologiche, Farmaceutiche, Università della Campania "Luigi Vanvitelli", Via Vivaldi 43, 81100 Caser…. Hauptthemen laut MEDLINE: Orexins, Polymorphism, Single Nucleotide, Orexin Receptors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orexin-A is a neuropeptide product of the lateral hypothalamus that acts on two receptors, OX1R and OX2R. The orexinergic system is involved in feeding, sleep, and pressure regulation. Recently, orexin-A levels have been found to be negatively correlated with renal function. Here, we analyzed orexin-A levels as well as the incidence of SNPs in the hypocretin neuropeptide precursor (HCRT) and its receptors, HCRTR1 and HCRTR2, in 64 patients affected by autosomal dominant polycystic kidney disease (ADPKD) bearing truncating mutations in the PKD1 or PKD2 genes. Twenty-four healthy volunteers constituted the control group. Serum orexin-A was assessed by ELISA, while the SNPs were investigated through Sanger sequencing. Correlations with the main clinical features of PKD patients were assessed. PKD patients showed impaired renal function (mean eGFR 67.8 ± 34.53) and a statistically higher systolic blood pressure compared with the control group (p < 0.001). Additionally, orexin-A levels in PKD patients were statistically higher than those in healthy controls (477.07 ± 69.42 pg/mL vs. 321.49 ± 78.01 pg/mL; p < 0.001). Furthermore, orexin-A inversely correlated with blood pressure (p = 0.0085), while a direct correlation with eGFR in PKD patients was found. None of the analyzed SNPs showed any association with orexin-A levels in PKD. In conclusion, our data highlights the emerging role of orexin-A in renal physiology and its potential relevance to PKD. Further research is essential to elucidate the intricate mechanisms underlying orexin-A signaling in renal function and its therapeutic implications for PKD and associated cardiovascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrexinsPolymorphism, Single NucleotideOrexin ReceptorsHumansMaleFemaleMiddle AgedAdultTRPP Cation ChannelsPolycystic Kidney, Autosomal DominantCase-Control StudiesAgedBlood PressurePolycystic Kidney Diseases

Stichwörter der Autor:innen

blood pressuremarkerorexin-Apolycystic kidney diseaserenal function

Substanzen

OrexinsOrexin ReceptorsTRPP Cation ChannelsHCRTR1 protein, humanHCRTR2 protein, human

Autor:innen und Institutionen

  • Dipartimento di Scienze e Tecnologie Ambientali, Biologiche, Farmaceutiche, Università della Campania "Luigi Vanvitelli", Via Vivaldi 43, 81100 Caserta, Italy.
  • CEINGE-Biotecnologie Avanzate Scarl "Franco Salvatore", Via G. Salvatore 486, 80145 Napoli, Italy.
  • Department of Human Sciences, Telematic University Pegaso, 80100 Naples, Italy.
  • Unità di Nefrologia, Dipartimento di Sanità Pubblica, Università di Napoli "Federico II", Via Pansini 5, 80131 Napoli, Italy.
  • Sezione di Fisiologia Umana e Unità di Dietetica e Medicina dello Sport, Dipartimento di Medicina Sperimentale, Università degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi "Federico II", Via Pansini 5, 80131 Napoli, Italy.

ORCID-Profile: Fiorenzo Moscatelli, Maria Amicone, Marcellino Monda

Zitieren

APA

Nigro, E., D'Arco, D., Moscatelli, F., Pisani, A., Amicone, M., Riccio, E., Capuano, I., Argentino, F., Monda, M., Messina, G., Daniele, A., & Polito, R. (2024). Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116243

Vancouver

Nigro E, D'Arco D, Moscatelli F, Pisani A, Amicone M, Riccio E, et al. Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116243

BibTeX
@article{Nigro2024,
  author = {Nigro, Ersilia and D'Arco, Daniela and Moscatelli, Fiorenzo and Pisani, Antonio and Amicone, Maria and Riccio, Eleonora and Capuano, Ivana and Argentino, Francesca and Monda, Marcellino and Messina, Giovanni and Daniele, Aurora and Polito, Rita},
  title = {Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25116243}
}
Kostenlos starten →